Guski L, Jurgens G, Pedder H, Levinsen N, Andersen S, Welton N
JAMA Netw Open. 2023; 6(10):e2335950.
PMID: 37801318
PMC: 10559183.
DOI: 10.1001/jamanetworkopen.2023.35950.
Lee E, Kim J, Lee H, Ryu J, Lee H, Sonn J
Front Pharmacol. 2019; 10:417.
PMID: 31105565
PMC: 6492527.
DOI: 10.3389/fphar.2019.00417.
Buer J
Inflammopharmacology. 2017; 25(2):185-190.
PMID: 28194545
PMC: 5360837.
DOI: 10.1007/s10787-017-0320-9.
Rau R
Clin Rheumatol. 2005; 24(3):189-202.
PMID: 15940552
DOI: 10.1007/s10067-004-0869-8.
Doi S, Kushida K, Miyamoto S, Sekioka Y, Suzuki M, Inoue T
Rheumatol Int. 2004; 25(3):195-200.
PMID: 14991230
DOI: 10.1007/s00296-003-0421-1.
Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives?.
Drosos A
Drugs Aging. 2003; 20(10):723-36.
PMID: 12875609
DOI: 10.2165/00002512-200320100-00002.
Disease-modifying antirheumatic drugs. Potential effects in older patients.
Gardner G, Furst D
Drugs Aging. 1995; 7(6):420-37.
PMID: 8601050
DOI: 10.2165/00002512-199507060-00003.
Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin.
Prete P, Zane J, Krailo M, Bulanowski M
Clin Rheumatol. 1994; 13(1):60-9.
PMID: 8187446
DOI: 10.1007/BF02229867.
Antirheumatic drugs: clinical pharmacology and therapeutic use.
Craig G, BUCHANAN W
Drugs. 1980; 20(6):453-84.
PMID: 7009134
DOI: 10.2165/00003495-198020060-00002.
Effect of in vivo administration of gold sodium thiomalate on rat macrophage function.
Turkall R, Warr G, Tsan M
Agents Actions. 1982; 12(4):489-98.
PMID: 6817620
DOI: 10.1007/BF01965932.
Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.
Williams H, WARD J, Egger M, Reading J, Samuelson C, Willkens R
Clin Rheumatol. 1984; 3 Suppl 1:39-50.
PMID: 6432412
DOI: 10.1007/BF03342621.
Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Chaffman M, Brogden R, Heel R, Speight T, Avery G
Drugs. 1984; 27(5):378-424.
PMID: 6426923
DOI: 10.2165/00003495-198427050-00002.
The long-term effects of treating rheumatoid arthritis.
Scott D, Coulton B, Chapman J, Bacon P, POPERT A
J R Coll Physicians Lond. 1983; 17(1):79-85.
PMID: 6402590
PMC: 5370976.
Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use.
Hart F, Huskisson E
Drugs. 1984; 27(3):232-55.
PMID: 6368185
DOI: 10.2165/00003495-198427030-00004.
The prophylactic and therapeutic effects of gold sodium thiomalate against adjuvant-induced polyarthritis in rats.
Sofia R, Douglas J
Agents Actions. 1973; 3(5):335-43.
PMID: 4206380
DOI: 10.1007/BF01986491.
A double-blind study on the effect of discontinuation of gold therapy in patients with rheumatoid arthritis.
van der Leeden H, Dijkmans B, Hermans J, Cats A
Clin Rheumatol. 1986; 5(1):56-61.
PMID: 3956116
DOI: 10.1007/BF02030968.
Joint damage in rheumatoid arthritis: radiological assessments and the effects of anti-rheumatic drugs.
Scott D, Bacon P
Rheumatol Int. 1985; 5(5):193-9.
PMID: 3906844
DOI: 10.1007/BF00541335.
Gold-induced aplastic anemia.
Williame L, Joos R, Proot F, Immesoete C
Clin Rheumatol. 1987; 6(4):600-5.
PMID: 3449312
DOI: 10.1007/BF02330601.
What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.
Spector T, Scott D
Clin Rheumatol. 1988; 7(3):315-30.
PMID: 3147831
DOI: 10.1007/BF02239187.
Aurothioglucose overdosage in five patients with rheumatoid arthritis.
Rubinstein I, Langevitz P, Pras M
Clin Rheumatol. 1987; 6(4):583-7.
PMID: 3130212
DOI: 10.1007/BF02330597.
